VIR logo

VIR

Vir Biotechnology Inc.

$9.61
+$0.44(+4.77%)
53
Overall
60
Value
50
Tech
50
Quality
How is this score calculated?
Market Cap
$720.67M
Volume
1.75M
52W Range
$4.16 - $10.94
Target Price
$20.78

Latest News for VIR

Medivir Calls 2026 AGM, Details Shareholder Voting Procedures and Capital Structure
TipRanks Sweden Auto-Generated Newsdesk20 hours agoApr 08, 2026

An update from Medivir AB ( ($SE:MVIR) ) is now available. Medivir AB has called its annual general meeting for 7 May 2026 in Stockholm, offering s......

Goldman Sachs Reaffirms Their Hold Rating on Virtu Financial (VIRT)
TipRanks Auto-Generated Intelligence Newsdeska day agoApr 07, 2026

In a report released yesterday, Alexander Blostein from Goldman Sachs maintained a Hold rating on Virtu Financial, with a price target of $46.00. A......

Goldman Sachs Reaffirms Their Hold Rating on Virtu Financial (VIRT)
TipRanks Auto-Generated Intelligence Newsdeska day agoApr 07, 2026

In a report released yesterday, Alexander Blostein from Goldman Sachs maintained a Hold rating on Virtu Financial, with a price target of $46.00. A......

Medivir sharpens focus on late-stage liver cancer and rare bone disease programs
TipRanks Sweden Auto-Generated Newsdesk8 days agoApr 01, 2026

Medivir AB ( ($SE:MVIR) ) has shared an announcement. Medivir is sharpening its focus on two proprietary programs aimed at serious conditions lacki......

Vidrala Ups Share Buyback to 2% of Capital to Boost EPS
TipRanks Spain Auto-Generated Newsdesk13 days agoMar 26, 2026

Vidrala ( ($ES:VID) ) has provided an announcement. Vidrala has decided to increase the size of its existing share buyback programme to cover up to......

Vidrala (0NV7) Gets a Buy from Kepler Capital
TipRanks Auto-Generated Intelligence Newsdesk15 days agoMar 25, 2026

Kepler Capital analyst Inigo Egusquiza maintained a Buy rating on Vidrala on March 23 and set a price target of €100.50. The company’s shares close......

Kepler Capital Remains a Buy on Viridien (0RI9)
TipRanks Auto-Generated Intelligence Newsdesk20 days agoMar 20, 2026

In a report released on March 18, Kevin Roger from Kepler Capital maintained a Buy rating on Viridien, with a price target of €180.00. The company’......

Kepler Capital Sticks to Their Buy Rating for Virbac SA (0NM7)
TipRanks Auto-Generated Intelligence Newsdesk20 days agoMar 20, 2026

In a report released on March 18, Christophe dombu from Kepler Capital maintained a Buy rating on Virbac SA, with a price target of €415.00. The co......

Citi Sticks to Their Hold Rating for Vidrala (0NV7)
TipRanks Auto-Generated Intelligence Newsdeska month agoMar 10, 2026

Citi analyst Ephrem Ravi maintained a Hold rating on Vidrala today and set a price target of €85.00. According to TipRanks, Ravi is a 5-star analys......

Virco Manufacturing Declares First-Quarter 2026 Cash Dividend
TipRanks Auto-Generated Newsdeska month agoMar 09, 2026

Virco Manufacturing ( ($VIRC) ) has provided an update. On March 5, 2026, Virco Mfg. Corporation’s board declared a cash dividend of $0.025 per sha......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 10 articles.

ABCD
1SymbolPriceChangeVol
2VIR$9.61+4.8%1.75M
3
4
5
6

Get Vir Biotechnology Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.